Detalhe da pesquisa
1.
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
J Infect Dis
; 225(11): 1923-1932, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35079784
2.
CCL8 and skin T cells--an allergic attraction.
Nat Immunol
; 12(2): 111-2, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21245898
3.
Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation.
J Immunol
; 195(8): 3531-6, 2015 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26355150
4.
Elevated TRF2 in advanced breast cancers with short telomeres.
Breast Cancer Res Treat
; 127(3): 623-30, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20625812
5.
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.
EClinicalMedicine
; 31: 100689, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33392485
6.
Safety, bioavailability, and pharmacokinetics of VGX-1027-A novel oral anti-inflammatory drug in healthy human subjects.
Clin Pharmacol Drug Dev
; 5(2): 91-101, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27138022
7.
Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.
Hum Vaccin Immunother
; 9(10): 2246-52, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24051434
8.
Elevated expression of nuclear Hsp90 in invasive breast tumors.
Cancer Biol Ther
; 8(20): 1952-61, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19738418